Kong Z - Search Results

1

A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.

Wang D, Wan X, Zhang Y, Kong Z, Lu Y, Sun X, Huang Y, Ji C, Li D, Luo J, Gu W, Wang C, Li Y, Xu Y. Wang D, et al. Among authors: kong z. Prostate. 2019 Sep;79(12):1362-1377. doi: 10.1002/pros.23840. Epub 2019 Jul 3. Prostate. 2019. PMID: 31269242

2

Increased expression of long non-coding RNA GLIDR in prostate cancer.

Zhang Y, Kong Z, Zhang Y, Huang W, Wu H, Wan X, Li Y. Zhang Y, et al. Among authors: kong z. Cancer Biomark. 2017;19(2):145-150. doi: 10.3233/CBM-160166. Cancer Biomark. 2017. PMID: 28211799

3

An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation.

Zhang Y, Su X, Kong Z, Fu F, Zhang P, Wang D, Wu H, Wan X, Li Y. Zhang Y, et al. Among authors: kong z. PLoS One. 2017 Aug 3;12(8):e0182305. doi: 10.1371/journal.pone.0182305. eCollection 2017. PLoS One. 2017. PMID: 28771526 Free PMC article.

4

Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.

Huang W, Su X, Yan W, Kong Z, Wang D, Huang Y, Zhai Q, Zhang X, Wu H, Li Y, Li T, Wan X. Huang W, et al. Among authors: kong z. Prostate. 2018 Dec;78(16):1248-1261. doi: 10.1002/pros.23700. Epub 2018 Aug 13. Prostate. 2018. PMID: 30105831

5

Androgen-responsive lncRNA LINC00304 promotes cell cycle and proliferation via regulating CCNA1.

Zhang P, Lu Y, Kong Z, Zhang Y, Fu F, Su X, Huang Y, Wan X, Li Y. Zhang P, et al. Among authors: kong z. Prostate. 2019 Jun;79(9):994-1006. doi: 10.1002/pros.23811. Epub 2019 Apr 23. Prostate. 2019. PMID: 31012142

6

Comprehensive Characterization of Androgen-Responsive lncRNAs Mediated Regulatory Network in Hormone-Related Cancers.

Wang D, Li M, Li J, Wan X, Huang Y, Wang C, Zhang P, Xu Y, Kong Z, Lu Y, Wang X, Liu C, Ji C, Li L. Wang D, et al. Among authors: kong z. Dis Markers. 2020 Sep 26;2020:8884450. doi: 10.1155/2020/8884450. eCollection 2020. Dis Markers. 2020. PMID: 33082888 Free PMC article.

7

Comprehensive Characterization of Androgen-Responsive circRNAs in Prostate Cancer.

Kong Z, Lu Y, Wan X, Luo J, Li D, Huang Y, Wang C, Li Y, Xu Y. Kong Z, et al. Life (Basel). 2021 Oct 15;11(10):1096. doi: 10.3390/life11101096. Life (Basel). 2021. PMID: 34685466 Free PMC article.

8

Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy.

Wan X, Pu H, Huang W, Yang S, Zhang Y, Kong Z, Yang Z, Zhao P, Li A, Li T, Li Y. Wan X, et al. Among authors: kong z. Oncotarget. 2016 Aug 9;7(32):51284-51300. doi: 10.18632/oncotarget.9992. Oncotarget. 2016. PMID: 27323416 Free PMC article.

9

Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer.

Zhang Y, Zhang P, Wan X, Su X, Kong Z, Zhai Q, Xiang X, Li L, Li Y. Zhang Y, et al. Among authors: kong z. Biomed Pharmacother. 2016 Oct;83:936-941. doi: 10.1016/j.biopha.2016.08.013. Epub 2016 Aug 11. Biomed Pharmacother. 2016. PMID: 27522256

10

Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression.

Wan X, Huang W, Yang S, Zhang Y, Zhang P, Kong Z, Li T, Wu H, Jing F, Li Y. Wan X, et al. Among authors: kong z. Int J Biochem Cell Biol. 2016 Oct;79:249-260. doi: 10.1016/j.biocel.2016.08.043. Epub 2016 Sep 1. Int J Biochem Cell Biol. 2016. PMID: 27594411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,244 results

Search Page

Filters